3 Live Webinars coming soon — Learn how to reduce risks in your raw materials supply chain - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

3 Live Webinars coming soon — Learn how to reduce risks in your raw materials supply chain


Supply chain security - how best to use the most important tool in supply chain protection

Infrared spectroscopy is the most economical way to screen against many of the risks that exist today in your supply chain of raw materials — counterfeit, contaminated, adulterated, diluted, substituted, false claims of purity/source etc.

Join us for a free webinar series to learn how PerkinElmer’s expertise can help improve your approach to supply chain security.

PROGRAM HIGHLIGHTS
These twenty minute webinars will be presented by our pharmaceutical IR application expert and will include a ten minute Q&A session to answer your specific questions or requests.
ATTEND ANY OF THE 3 WEBINARS AND DOWNLOAD YOUR COMPLIANCE RESOURCE KIT

1. Raw material identification in the Pharmaceutical industry. Why and how?
2nd October 2012 at 10:00 - 10:30am CET

2. Method development and instrument validation
9th October 2012 at 10:00 - 10:30am CET

3. Optimizing the performance of your instrument in IR Spectroscopy
16th October 2012 at 10:00 - 10:30am CET

PRESENTER: Kelly Palmer, Infrared Spectroscopy Pharmaceutical Specialist
MODERATOR: Gavin Aston, 'Safety & Security' Market Development Manager and U.K. & Ireland Analytical Sales Leader

WE PROMISE THAT YOU WILL:

  • Learn how to bring potential productivity improvements to existing and new infrared quality control procedures.
  • Find out how new best practices and techniques can reduce wastage and costs.
  • Enhance your personal and team knowledge and skills.

WHO SHOULD ATTEND THIS WEBINAR PROGRAM?
You should attend if you are a user, method developer, validation specialist or manager involved with infrared spectroscopy within a regulated laboratory.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here